Revolo Biotherapeutics Limited

Active07828414 Private limited company

Incorporated: 31 October 2011 (15 years)
Previously known as: Immune Regulation Limited (until 27 February 2021)
Peptinnovate Limited (until 3 October 2018)
Newincco 1132 Limited (until 18 November 2011)
This list may be incomplete. See all names on Companies House
Industry: Research and experimental development on biotechnology (72110)
Directors: Marek Stefan Gumienny
Gunnar Jan Walstam
Jones Woodrow Bryan
all 9 directors
Accounts type: Total exemption full
Region: East of England
Address: C/o Windsor House Station Court
Station Road
Great Shelford
Cambridge
CB22 5NE

Filing status

Accounts due: 31 December 2027
Last accounts: 31 March 2026
Conf. stmt due: 14 November 2026
Last conf. stmt: 31 October 2025

Charges

Total: 2
Outstanding: 1
Part satisfied: 0
Satisfied: 1

Officers 10 active

Officer details are public data from the Companies House register.

Gumienny, Marek Stefan

Director · Appointed 12 December 2025

British

Born March 1959 (67)

Walstam, Gunnar Jan

Director · Appointed 15 July 2025

Swiss,Swedish

Born May 1955 (71)

Bryan, Jones Woodrow

Director · Appointed 3 January 2024

Also at IR 2018 Limited

American

Born August 1964 (62)

Otulana, Babatunde, Dr

Director · Appointed 1 August 2021

American

Born August 1956 (70)

Giovannetti, Glen Thomas

Director · Appointed 1 July 2021

American

Born October 1962 (64)

Persky, Marla Susan

Director · Appointed 1 July 2021

American

Born February 1956 (70)

Albisser, Michael

Director · Appointed 25 January 2021

Swiss

Born September 1969 (57)

Greenleaf, Peter Scott

Director · Appointed 23 November 2020

American

Born February 1970 (56)

Cheng, Isaac S.

Director · Appointed 17 September 2020

Also at Medannex Limited, 30 Technology Limited, Thirty Holdings Limited · more companies

American

Born April 1975 (51)

Bcs Cosec Limited

Corporate Secretary · Appointed 21 November 2014

Also at Lansharks (UK) Limited, Rcma Agricultural Storage Limited, Bennbridge Hold Co Ltd · more companies

Officer history (18 former)

12 December 2025

Appointed Gumienny, Marek Stefan as Director

15 July 2025

Appointed Walstam, Gunnar Jan as Director

19 May 2025

Resigned Southwell, David Peabody as Director

3 January 2024

Appointed Bryan, Jones Woodrow as Director

3 January 2024

Resigned Rigby, Jonathan Michael Norman as Director

15 December 2023

Appointed Southwell, David Peabody as Director

1 August 2021

Appointed Otulana, Babatunde, Dr as Director

1 July 2021

Appointed Giovannetti, Glen Thomas as Director

1 July 2021

Appointed Persky, Marla Susan as Director

25 January 2021

Appointed Albisser, Michael as Director

27 November 2020

Resigned Escher, Dominik as Director

23 November 2020

Appointed Greenleaf, Peter Scott as Director

23 October 2020

Resigned Page, Clive as Director

17 September 2020

Appointed Cheng, Isaac S. as Director

17 September 2020

Resigned Albisser, Michael as Director

17 September 2020

Resigned Walstam, Gunnar as Director

17 September 2020

Resigned Smith, Christopher as Director

3 July 2020

Resigned Nagle, Richard as Director

1 April 2020

Appointed Rigby, Jonathan Michael Norman as Director

14 February 2020

Resigned Cons, Ben Major George, Dr as Director

24 October 2019

Resigned Beadle, David Colin as Director

30 November 2018

Appointed Walstam, Gunnar as Director

1 November 2018

Appointed Escher, Dominik as Director

12 October 2018

Appointed Cons, Ben Major George, Dr as Director

31 July 2018

Resigned Martin, Anthony Francis, Dr as Director

14 December 2017

Appointed Smith, Christopher as Director

31 August 2017

Resigned Plouvier, Thierry as Director

22 June 2017

Appointed Beadle, David Colin as Director

11 February 2017

Resigned Lightfoot, Andrew Phillip, Dr as Director

25 April 2016

Appointed Martin, Anthony Francis, Dr as Director

28 July 2015

Resigned Van Kaathoven, Erik as Director

28 July 2015

Appointed Albisser, Michael as Director

21 November 2014

Appointed Bcs Cosec Limited as Corporate Secretary

21 November 2014

Resigned Olswang Cosec Limited as Corporate Secretary

1 April 2014

Appointed Nagle, Richard as Director

1 April 2014

Appointed Page, Clive as Director

1 April 2014

Appointed Plouvier, Thierry as Director

1 April 2014

Appointed Van Kaathoven, Erik as Director

17 November 2011

Appointed Lightfoot, Andrew Phillip, Dr as Director

17 November 2011

Resigned Mackie, Christopher Alan as Director

17 November 2011

Resigned Olswang Directors 1 Limited as Corporate Director

17 November 2011

Resigned Olswang Directors 2 Limited as Corporate Director

31 October 2011

Appointed Mackie, Christopher Alan as Director

31 October 2011

Appointed Olswang Directors 1 Limited as Corporate Director

31 October 2011

Appointed Olswang Directors 2 Limited as Corporate Director

31 October 2011

Appointed Olswang Cosec Limited as Corporate Secretary

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.

Holdings 1

Companies where Revolo Biotherapeutics Limited is registered as a person with significant control

IR 2018 Limited

Owns 75–100% of shares

Active

Filings

Recent filings only. See the full history on Companies House

Date	Description	Made Up To
5 November 2026	Statement of capital following an allotment of shares
5 November 2026	Statement of capital following an allotment of shares
3 September 2026	Total exemption full accounts	31 March 2026
17 August 2026	Statement of capital following an allotment of shares
3 August 2026	Appointment of a director